Rate of major adverse renal or cardiac events with iohexol compared to other low osmolar contrast media during interventional cardiovascular procedures.

ABSTRACT:

Objective

This study assessed the rate of major adverse renal or cardiac events (MARCE) when iohexol is used during interventional cardiovascular procedures compared to other low osmolar contrast media (LOCMs).

Background

Interventional cardiovascular procedures are often essential for diagnosis and treatment, the risk of MARCE should be considered.

Methods

Data were derived from the Premier Hospital Database January 1, 2010 through September 30, 2015. Patient encounters with an inpatient primary interventional cardiovascular procedure with a single LOCM (iohexol, ioversol, ioxilan, ioxaglate, or iopamidol) were included. The primary outcome was a composite endpoint of MARCE, which included: renal failure with dialysis, acute kidney injury (AKI) with or without dialys

SUBMITTER: McCullough PA 

PROVIDER: S-EPMC6585608 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature